Tick-borne encephalitis (TBE) vaccination: Applying the most suitable vaccination schedule

Vaccine

Volumn 25, Issue 8, 2007, Pages 1470-1475

  Schondorf I ^a   Beran, J ^b   Cizkova, D ^b   Lesna, V ^b   Banzhoff, A ^a   Zent, O ^a  

^a Pharmaserv GmbH and Co KG   (Germany)

^b Vaccination and Travel Medicine Centre   (Czech Republic)

Author keywords

Primary vaccination; Schedules; TBE; Tick borne encephalitis

Indexed keywords

TICK BORNE ENCEPHALITIS VACCINE;

ADOLESCENT; ADULT; ANTIBODY BLOOD LEVEL; ANTIBODY TITER; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG FEVER; DRUG INDUCED HEADACHE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNE RESPONSE; IMMUNIZATION; INFECTION PREVENTION; MALE; MYALGIA; NORMAL HUMAN; PAIN; PRIORITY JOURNAL; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; SERODIAGNOSIS; SINGLE DRUG DOSE; TICK BORNE ENCEPHALITIS; VACCINATION;

ADOLESCENT; ADULT; CHILD; ENCEPHALITIS VIRUSES, TICK-BORNE; ENCEPHALITIS, TICK-BORNE; FEMALE; HUMANS; IMMUNIZATION SCHEDULE; MALE; MIDDLE AGED; VIRAL VACCINES;

EID: 33846204617     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2006.10.028     Document Type: Article

References (20)

1. Charrel R.N., Attoui H., Butenko A.M., Clegg J.C., Deubel V., Frolova T.V., et al. Tick-borne virus diseases of human interest in Europe. Clin Microbiol Infect 10 December (12) (2004) 1040-1055
2. Beran J. Tick-borne encephalitis in the Czech Republic. Eurosurveillance Wkly 8 June (26) (2004)
3. Beran J. Tick-borne encephalitis in the Czeck Republic-advice for travelers. Eurosurveillance Wkly 5 March (13) (2001)
4. Beran J. Immunisation against tick-borne encephalitis by widely used vaccines: short-term history and current recommendations. Clin Microbiol Infect 11 May (5) (2005) 424-426
5. CDC. Current trends field evaluations of pre-exposure use of human diploid cell rabies vaccine. MMWR 32 November (46) (1983) 601-603
6. Klockmann U., Bock H.L., Franke V., Hein B., Reiner G., and Hilfenhaus J. Preclinical investigations of the safety, immunogenicity and efficacy of a purified, inactivated tick-borne encephalitis vaccine. J Biol Stand 17 October (4) (1989) 331-342
7. Zent O., Banzhoff A., Hilbert A.K., Meriste S., Sluzewski W., and Wittermann C. Safety, immunogenicity and tolerability of a new pediatric tick-borne encephalitis (TBE) vaccine, free of protein-derived stabilizer. Vaccine 21 September (25-26) (2003) 3584-3592
8. Zent O., Beran J., Jilg W., Mach T., and Banzhoff A. Clinical evaluation of a polygeline-free tick-borne encephalitis vaccine for adolescents and adults. Vaccine 21 January (7-8) (2003) 738-741
9. CDC. Current trends field evaluations of pre-exposure use of human diploid cell rabies vaccine. MMWR 32 November (46) (1983) 601-603
10. Defraites R.F., Gambel J.M., Hoke Jr. C.H., Sanchez J.L., Withers B.G., Karabatsos N., et al. Japanese encephalitis vaccine (inactivated, BIKEN) in U.S. soldiers: immunogenicity and safety of vaccine administered in two dosing regimens. Am J Trop Med Hyg 61 August (2) (1999) 288-293
11. Girgsdies O.E., and Rosenkranz G. Tick-borne encephalitis: development of a paediatric vaccine. A controlled, randomized, double-blind and multicentre study. Vaccine 14 October (15) (1996) 1421-1428
12. Bock H.L., Klockmann U., Jungst C., Schindel-Kunzel F., Theobald K., and Zerban R. A new vaccine against tick-borne encephalitis: initial trial in man including a dose-response study. Vaccine 8 February (1) (1990) 22-24
13. Ehrlich H.J., Pavlova B.G., Fritsch S., Poellabauer E.M., Loew-Baselli A., Obermann-Slupetzky O., et al. Randomized, phase II dose-finding studies of a modified tick-borne encephalitis vaccine: evaluation of safety and immunogenicity. Vaccine 22 December (2) (2003) 217-223
14. Zent O., Plentz A., Schwarz T.F., Fruhwein N., Kuhr H.B., Broeker M., et al. TBE booster immunization according to the rapid immunization schedule: are 3-year booster intervals really necessary?. Vaccine 23 December (3) (2004) 312-315
15. Rendi-Wagner P., Kundi M., Zent O., Dvorak G., Jaehnig P., Holzmann H., et al. Persistence of protective immunity following vaccination against tick-borne encephalitis-longer than expected?. Vaccine 22 (2004) 2743-2749
16. Craig S.C., Pittman P.R., Lewis T.E., Rossi C.A., Henchal E.A., Kuschner R.A., et al. An accelerated schedule for tick-borne encephalitis vaccine: the American Military experience in Bosnia. Am J Trop Med Hyg 61 December (6) (1999) 874-878
17. Harabacz I., Bock H., Jungst C., Klockmann U., Praus M., and Weber R. A randomized phase II study of a new tick-borne encephalitis vaccine using three different doses and two immunization regimens. Vaccine 10 3 (1992) 145-150
18. ® Erwachsene: Der, neue" FSME-Impfstoff von Baxter. Ellipse 18 2 (2002) 41-42
19. Loew-Baselli A., Poellabauer E.M., Fritsch S., Koska M., Vartian N., Himly C., et al. Immunogenicity and safety of FSME-Immun 0.5 mL using a rapid immunizaiton schedule. Int J Med Microbiol 296 S1 (2006) 213-214
20. Zent O., Jilg W., Plentz A., Schwarz T.F., Fruhwein N., Kuhr H.B., et al. Kinetics of the immune response after primary and booster immunization against tick-borne encephalitis (TBE) in adults using the rapid immunization schedule. Vaccine 21 December (32) (2003) 4655-4660